Clinical Trials

Carcinoma, Head and Neck Neoplasms

NCT06093503 2024-06-26

Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein

Carcinoma, Non-Small-Cell Lung

NCT05791097 2023-07-24

AdvanTIG-306

Carcinoma, Non-Small-Cell Lung

NCT04806945 2022-05-05

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT04859582 2021-12-16

KEYNOTE-859

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03673735 2021-05-10

ADHERE

Squamous Cell Carcinoma of Head and Neck

NCT04203511 2020-06-09

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Carcinoma, Non-Small-Cell Lung

NCT03579758 2020-06-05

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Gallbladder Neoplasms

NCT03881111 2020-02-11

KEYNOTE-590

Esophageal Neoplasms

NCT03342352 2019-12-20

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03386838 2019-04-18

An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

NCT03081039 2018-02-19

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Cholangiocarcinoma

NCT02795884 2016-12-30

Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation

Lung Neoplasms

NCT01998347 2015-11-20

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Esophageal Neoplasms

NCT00907504 2014-06-17

ADVIGO1017

Carcinoma, Non-Small-Cell Lung

NCT00238160 2013-05-30

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Localized Resectable Adult Primary Liver Cancer

NCT00055887 2013-05-10

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00057928 2012-06-13

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT01327521 2012-06-11

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00329472 2010-08-27

Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer